Clinical review: Biomarkers of acute kidney injury: where are we now?

Critical Care

Volumn 16, Issue 5, 2012, Pages

  Ostermann, Marlies ^a   Philips, Barbara J ^b   Forni, Lui G ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALGRANULIN; CYSTATIN C; FATTY ACID BINDING PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; HEPCIDIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; LIVER TYPE FATTY ACID BINDING PROTEIN; MICROSOMAL AMINOPEPTIDASE; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYL BETA GLUCOSAMINIDASE; NETRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN; SCATTER FACTOR; SODIUM; UNCLASSIFIED DRUG; UREA; ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; FABP1 PROTEIN, HUMAN; GLUTATHIONE; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; NERVE GROWTH FACTOR; NETRIN-1; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; AREA UNDER THE CURVE; CLINICAL PRACTICE; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MICROSCOPY; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; REVIEW; SODIUM EXCRETION; URINE VOLUME; ACUTE KIDNEY INJURY; METABOLISM; MICTURITION; URINE;

ACETYLGLUCOSAMINIDASE; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOMARKERS; CYSTATIN C; EARLY DIAGNOSIS; FATTY ACID-BINDING PROTEINS; GLUTATHIONE; HEPCIDINS; HUMANS; INTERLEUKIN-18; LEUKOCYTE L1 ANTIGEN COMPLEX; LIPOCALINS; MEMBRANE GLYCOPROTEINS; MICROSCOPY; NERVE GROWTH FACTORS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; SODIUM; TUMOR SUPPRESSOR PROTEINS; UREA; URINATION; URINE;

EID: 84866870745     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11380     Document Type: Review

References (91)

1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, . ADQI workgroup Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212. 10.1186/cc2872, 522841, 15312219, ADQI workgroup.
2. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, . Acute Kidney Injury Network Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245, Acute Kidney Injury Network.
3. NCEPOD Adding Insult to Injury NCEPOD., http://www.ncepod.org.uk/2009report1/Downloads/AKI_summary.pdf
4. American Society of Nephrology Renal Research Report. J Am Soc Nephrol 2005, 16:1886-1903.
5. de Geus HR, Woo JG, Wang Y, Devarajan P, Betjes MG, le Noble JL, Bakker J. Urinary NGAL measured on admission to the Intensive Care Unit accurately discriminates between sustained and transient acute kidney injury in adult critically ill patients. Nephron Extra 2011, 1:9-23. 10.1159/000330428, 3290847, 22470375.
6. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, Elger A, Maarouf O, Sola-Del Valle DA, O'Rourke M, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, Barasch J. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage a multicenter prospective cohort study. J Am Coll Cardiol 2012, 59:246-255. 10.1016/j.jacc.2011.10.854, 22240130.
7. Hall IE, Coca SG, Perazella MA, Eko UU, Luciano RL, Peter PR, Han WK, Parikh CR. Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis. Clin J Am Soc Nephrol 2011, 6:2740-2749. 10.2215/CJN.04960511, 22034509.
8. Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein CL, Walker RJ, Endre ZH. Some biomarkers of acute kidney injury are increased in prerenal acute injury. Kidney Int 2012, 81:1254-1262. 10.1038/ki.2012.23, 3365288, 22418979.
9. Singer E, Elger A, Elitok S, Kettritz R, Nickolas TL, Barasch J, Luft FC, Schmidt-Ott KM. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 2011, 80:405-414. 10.1038/ki.2011.41, 21412214.
10. Heller F, Frischmann S, Grünbaum M, Zidek W, Westhoff TH. Urinary calprotectin and the distinction between pre-renal and intrinsic acute kidney injury. Clin J Am Soc Nephrol 2011, 6:2347-2355. 10.2215/CJN.02490311, 21885792.
11. Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, Piccinni P, Ronco C. Plasma neutrophil gelatinase-associated lipcalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010, 36:444-451. 10.1007/s00134-009-1711-1, 2820221, 19956925.
12. Constantin JM, Futier E, Perbet S, Roszyk L, Lautrette A, Gillart T, Guerin R, Jabaudon M, Souweine B, Bazin JE, Sapin V. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 2010, 25:176.e1-6. 10.1016/j.jcrc.2009.05.010, 19781900.
13. Endre ZH, Pickering JW, Walker RJ, Devarajan P, Edelstein CL, Bonventre JV, Frampton CM, Bennett MR, Ma Q, Sabbisetti VS, Vaidya VS, Walcher AM, Shaw GM, Henderson SJ, Nejat M, Schollum JB, George PM. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011, 79:1119-1130. 10.1038/ki.2010.555, 21307838.
14. De Geus HR, Bakker J, Lesaffre EM, le Noble JL. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011, 183:907-914. 10.1164/rccm.200908-1214OC, 20935115.
15. Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2011, 58:356-365. 10.1053/j.ajkd.2011.02.389, 21601330.
16. Royakkers AA, Korevaar JC, van Suijlen JD, Hofstra LS, Kuiper MA, Spronk PE, Schultz MJ, Bouman CS. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 2011, 37:493-501. 10.1007/s00134-010-2087-y, 3042095, 21153403.
17. Doi K, Negishi K, Ishizu T, Katagiri D, Fujita T, Matsubara T, Yahagi N, Sugaya T, Noiri E. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 2011, 39:2464-2469. 10.1097/CCM.0b013e318225761a, 21705884.
18. Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, Arenja N, Klima T, Züsli C, Reichlin T, Potocki M, Twerenbold R, Steiger J, Mueller C. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012, 16:R2. 10.1186/cc10600, 3396227, 22226205.
19. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson K, Milzman D, Gaieski DF, Goyal M, Cairns CB, Kupfer K, Lee SW, Rivers EP. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010, 56:52-59. 10.1016/j.annemergmed.2010.02.010, 20363526.
20. Koyner JL, Garg AX, Coca SG, Sint K, Thiessen-Philbrook H, Patel UD, Shlipak MG, Parikh CR, . TRIBE-AKI Consortium Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 2012, 23:905-914. 10.1681/ASN.2011090907, 22383693, TRIBE-AKI Consortium.
21. Bell M, Granath F, Martensson J, Lofberg E, Ekbom A, Martling CR. Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant 2009, 24:3096-3102. 10.1093/ndt/gfp196, 19395727.
22. Nejat M, Pickering JW, Walker RJ, Endre ZH. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010, 25:3283-3289. 10.1093/ndt/gfq176, 20350927.
23. Srisawat N, Murugan R, Lee M, Kong L, Carter M, Angus DC, Kellum JA, . Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Investigators Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int 2011, 80:545-552. 10.1038/ki.2011.160, 3257035, 21677634, Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Investigators.
24. Hollmen ME, Kyllonen LE, Inkinen KA, Lalla ML, Merenmies J, Salmela KT. Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit Care 2011, 15:R121. 10.1186/cc10220, 3218974, 21545740.
25. Bataille A, Abbas S, Semoun O, Bourgeois T, Marie O, Bonnet F, Resche-Rigon M, Abboud I, Losser MR, Jacob L. Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation 2011, 92:1024-1030.
26. Cruz DN, De Geus HR, Bagshaw SM. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial 2011, 24:124-131. 10.1111/j.1525-139X.2011.00830.x, 21517976.
27. Herget-Rosenthal S, Marggraf G, Hüsing J, Göring F, Pietruck F, Janssen O, Philipp T, Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66:1115-1122. 10.1111/j.1523-1755.2004.00861.x, 15327406.
28. Perianayagam MC, Seabra VF, Tighiouart H, Liangos O, Jaber BL. Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 2009, 54:1025-1033. 10.1053/j.ajkd.2009.05.022, 19660848.
29. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:904-912. 10.1681/ASN.2006030221, 17267747.
30. Lameire NH, Vanholder RC, Van Biesen WA. How to use biomarkers efficiently in acute kidney injury. Kidney Int 2011, 79:1047-1050. 10.1038/ki.2011.21, 21527944.
31. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008, 148:810-819. 2909852, 18519927.
32. Cullen MR, Murray PT, Fitzgibbon MC. Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin. Ann Clin Biochem 2012, 49:190-193. 10.1258/acb.2011.011105, 22323662.
33. McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 2010, 5:211-219. 10.2215/CJN.04240609, 2827603, 20056755.
34. Waikar SS, Sabbisetti VS, Bonventre JV. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010, 78:486-494. 10.1038/ki.2010.165, 3025699, 20555318.
35. Goldstein SL. Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not?. Kidney Int 2010, 78:433-435. 10.1038/ki.2010.200, 20706215.
36. Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG, Wickersham N, Bossert F, Ikizler TA. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009, 20:1823-1832. 10.1681/ASN.2008070673, 2723988, 19628673.
37. Espinel CH. The FENa test. Use in the differential diagnosis of acute renal failure. JAMA 1976, 236:579-581. 10.1001/jama.1976.03270060029022, 947239.
38. Perazella MA, Coca SG. Traditional urinary biomarkers in the assessment of hospital-acquired AKI. Clin J Am Soc Nephrol 2012, 7:167-174. 10.2215/CJN.09490911, 22096038.
39. Marcussen N, Schumann J, Campbell P, Kjellstrand C. Cytodiagnostic urinalysis is very useful in the differential diagnosis of acute renal failure and can predict the severity. Ren Fail 1995, 17:721-729. 10.3109/08860229509037640, 8771245.
40. Chawla LS, Dommu A, Berger A, Shih S, Patel SS. Urinary sediment cast scoring index for acute kidney injury: A pilot study. Nephron Clin Pract 2008, 110:c145-c150. 10.1159/000166605, 2605880,2605880, 18953176.
41. Perazella MA, Coca SG, Hall IE, Iyanam U, Koraishy M, Parikh CR. Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2010, 5:402-408. 10.2215/CJN.06960909, 2827582, 20089493.
42. Bagshaw SM, Haase M, Haase-Fielitz A, Bennett M, Devarajan P, Bellomo R. A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury. Nephrol Dial Transplant 2012, 27:582-588. 10.1093/ndt/gfr331, 21669886.
43. Molitoris BA, Levin A, Warnock DG, Joannidis M, Mehta RL, Kellum JA, Ronco C, Shah S, . Acute Kidney Injury Network Improving outcomes from acute kidney injury. J Am Soc Nephrol 2007, 18:1992-1993. 10.1681/ASN.2007050567, 17596636, Acute Kidney Injury Network.
44. Cerda J. Oliguria: an earlier and accurate biomarker of acute kidney injury?. Kidney Int 2011, 80:699-701. 10.1038/ki.2011.177, 21918558.
45. Macedo E, Malhotra R, Bouchard J, Wynn SK, Mehta RL. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011, 80:760-767. 10.1038/ki.2011.150, 21716258.
46. Legrand M, Payen D. Understanding urine output in critically ill patients. Ann Intensive Care 2011, 1:13. 10.1186/2110-5820-1-13, 3224471, 21906341.
47. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011, 57:1752-1761. 10.1016/j.jacc.2010.11.051, 21511111.
48. Parikh CR, Garg AX. Acute kidney injury: better biomarkers and beyond. Kidney Int 2008, 73:801-803. 10.1038/ki.2008.17, 18340352.
49. Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JB, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010, 77:1020-1030. 10.1038/ki.2010.25, 20164823.
50. Waring WS, Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin Toxicol (Phila). 2011, 49:720-728. 10.3109/15563650.2011.615319, 21970770.
51. Dieterle F, Sistare F, Goodsaid F, Papaluca M, Ozer JS, Webb CP, Baer W, Senagore A, Schipper MJ, Vonderscher J, Sultana S, Gerhold DL, Phillips JA, Maurer G, Carl K, Laurie D, Harpur E, Sonee M, Ennulat D, Holder D, Andrews-Cleavenger D, Gu YZ, Thompson KL, Goering PL, Vidal JM, Abadie E, Maciulaitis R, Jacobson-Kram D, Defelice AF, Hausner EA, et al. Renal biomarker qualification submission: A dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol 2010, 28:455-462. 10.1038/nbt.1625, 20458315.
52. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, Wild P, Genth-Zotz S, Warnholtz A, Giannitsis E, Möckel M, Bickel C, Peetz D, Lackner K, Baldus S, Münzel T, Blankenberg S. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011, 306:2684-2693. 10.1001/jama.2011.1896, 22203537.
53. Liangos O, Tighiouart H, Perianayagam MC, Kolyada A, Han WK, Wald R, Bonventre JV, Jaber BL. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 2009, 14:423-431. 10.1080/13547500903067744, 2743298, 19572801.
54. Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study. Crit Care Med 2009, 37:553-560. 10.1097/CCM.0b013e318195846e, 19114878.
55. Haase M, Bellomo R, Devarajan P, Ma Q, Bennett MR, Möckel M, Matalanis G, Dragun D, Haase-Fielitz A. Novel biomarkers predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg 2009, 88:124-130. 10.1016/j.athoracsur.2009.04.023, 19559209.
56. Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008, 74:1059-1069. 10.1038/ki.2008.341, 2745082, 18650797.
57. Tuladhar SM, Puntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury following cardiopulmonary bypass. J Cardiovasc Pharmacol 2009, 53:261-266. 10.1097/FJC.0b013e31819d6139, 19247188.
58. Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009, 4:873-882. 10.2215/CJN.04810908, 2676184, 19406962.
59. Xin C, Yulong X, Yu C, Changchun C, Feng Z, Xinwei M. Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail 2008, 30:904-913. 10.1080/08860220802359089, 18925531.
60. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 2008, 52:425-433. 10.1053/j.ajkd.2008.05.018, 18649981.
61. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006, 105:485-491. 10.1097/00000542-200609000-00011, 16931980.
62. Haase-Fielitz A, Bellomo R, Devarajan P, Bennett M, Story D, Matalanis G, Frei U, Dragun D, Haase M. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant 2009, 24:3349-3354. 10.1093/ndt/gfp234, 19474273.
63. Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX, . TRIBE-AKI Consortium Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011, 22:1748-1757. 10.1681/ASN.2010121302, 3171945, 21836143, TRIBE-AKI Consortium.
64. Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron 2008, 108:c176-181.
65. Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, Riesen W, Wüthrich RP. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 2004, 61:98-102.
66. Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D'amico G, Goldsmith D, Devarajan P, Bellomo R. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med 2010, 36:452-461. 10.1007/s00134-009-1724-9, 19956924.
67. Mårtensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR. Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 2010, 36:1333-1340. 10.1007/s00134-010-1887-4, 20397003.
68. Makris K, Markou N, Evodia E, Dimopoulou E, Drakopoulos I, Ntetsika K, Rizos D, Baltopoulos G, Haliassos A. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 2009, 47:79-82.
69. Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010, 21:189-197. 10.1681/ASN.2009030264, 2799276, 19762491.
70. Yang HN, Boo CS, Kim MG, Jo SK, Cho WY, Kim HK. Urine neutrophil gelatinase-associated lipocalin: an independent predictor of adverse outcomes in acute kidney injury. Am J Nephrol 2010, 31:501-509. 10.1159/000309841, 20453495.
71. Kümpers P, Hafer C, Lukasz A, Lichtinghagen R, Brand K, Fliser D, Faulhaber-Walter R, Kielstein JT. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury. Crit Care 2010, 14:R9. 10.1186/cc8861, 2875521, 20122150.
72. Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 2008, 31:255-258. 10.1159/000143726, 18600028.
73. Villa P, Jimenez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005, 9:R139-143. 10.1186/cc3044, 1175926, 15774046.
74. Wald R, Liangos O, Perianayagam MC, Kolyada A, Herget-Rosenthal S, Mazer CD, Jaber BL. Plasma cystatin C and acute kidney injury after cardiopulmonary bypass. Clin J Am Soc Nephrol 2010, 5:1373-1379. 10.2215/CJN.06350909, 2924412, 20522534.
75. Ling Q, Xu X, Li JJ, Chen J, Shen JW, Zheng SS. Alternative definition of acute kidney injury following liver transplantation: based on serum creatinine and cystatin C levels. Transplant Proc 2007, 39:3257-3260. 10.1016/j.transproceed.2007.03.107, 18089366.
76. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S. Could neutrophil gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?. Kidney Blood Press Res 2007, 30:408-415. 10.1159/000109102, 17901710.
77. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 2008, 1:200-208. 10.1111/j.1752-8062.2008.00053.x, 2638059, 19212447.
78. Herget-Rosenthal S, Poppen D, Hüsing J, Marggraf G, Pietruck F, Jakob HG, Philipp T, Kribben A. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004, 50:552-558. 10.1373/clinchem.2003.027763, 14709451.
79. Daniel JP, Chantrel F, Offner M, Moulin B, Hanndedouche T. Comparison of cystatin C, creatinine and creatinine clearance versus GFR for detection of renal failure in renal transplant patients. Ren Fail 2004, 26:253-257. 10.1081/JDI-120039523, 15354974.
80. Ahlstrom A, Tailgren M, Peltonen S, Pettila V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 2004, 62:344-350.
81. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006, 6:1639-1645. 10.1111/j.1600-6143.2006.01352.x, 16827865.
82. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, Dent C, Devarajan P, Edelstein CL. Urinary IL-18 is an early predictive biomarker of acute kidney after cardiac surgery. Kidney Int 2006, 70:199-203. 10.1038/sj.ki.5001527, 16710348.
83. Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005, 16:3046-3052. 10.1681/ASN.2005030236, 16148039.
84. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008, 73:863-869. 10.1038/sj.ki.5002715, 2586909, 18059454.
85. Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009, 4:873-882. 10.2215/CJN.04810908, 2676184, 19406962.
86. Metzger J, Kirsch T, Schiffer E, Ulger P, Mentes E, Brand K, Weissinger EM, Haubitz M, Mischak H, Herget-Rosenthal S. Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int 2010, 78:1252-1262. 10.1038/ki.2010.322, 20827258.
87. Ferguson MA, Vaidya VS, Waikar SS, Collings FB, Sunderland KE, Gioules CJ, Bonventre JV. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010, 77:708-714. 10.1038/ki.2009.422, 2880954, 19940842.
88. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006, 47:439-444. 10.1053/j.ajkd.2005.11.006, 16490622.
89. McMahon BA, Koyner JL, Murray PT. Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review. Curr Opin Crit Care 2010, [Epub ahead of print], 10.1097/MCC.0b013e32833fdd9a, 20930627.
90. Ramesh G, Krawczeski CD, Woo JG, Wang Y, Devarajan P. Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2010, 5:395-401. 10.2215/CJN.05140709, 2827571, 20007677.
91. Prowle JR, Ostland V, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Bagshaw SM, Haase-Fielitz A, Haase M, Westerman M, Bellomo R. Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass. Nephrol Dial Transplant 2012, 27:595-602. 10.1093/ndt/gfr387, 21804084.